Haleh Saber
- Molecular Biology
- Oncology top 5%
- Hematology top 5%
- Genetics top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- John K. LeightonRichard PazdurAnn T. FarrellRobert JusticeJeffrey C. HansenBorries DemelerRajeshwari SridharaBrian Booth
- Topics
- Chronic Lymphocytic Leukemia Research (5 papers)CAR-T cell therapy research (4 papers)Chronic Myeloid Leukemia Treatments (3 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- United StatesEgyptUnited Kingdom
In The Last Decade
Haleh Saber
20 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Molecular Biology 624
- Oncology 606
- Hematology 276
- Genetics 243
- Radiology, Nuclear Medicine and Imaging 235
Countries citing papers authored by Haleh Saber
This map shows the geographic impact of Haleh Saber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haleh Saber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haleh Saber more than expected).
Fields of papers citing papers by Haleh Saber
This network shows the impact of papers produced by Haleh Saber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haleh Saber. The network helps show where Haleh Saber may publish in the future.
Co-authorship network of co-authors of Haleh Saber
This figure shows the co-authorship network connecting the top 25 collaborators of Haleh Saber. A scholar is included among the top collaborators of Haleh Saber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haleh Saber. Haleh Saber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | Trends in the approval of cancer therapies by the FDA in the twenty-first centurybreakdown → | 155 |
| 3 | 8 | |
| 4 | 5 | |
| 5 | 61 | |
| 6 | 2 | |
| 7 | 6 | |
| 8 | 60 | |
| 9 | 6 | |
| 10 | 33 | |
| 11 | 117 | |
| 12 | 86 | |
| 13 | 32 | |
| 14 | 73 | |
| 15 | 107 | |
| 16 | 100 | |
| 17 | 190 | |
| 18 | 12 | |
| 19 | 398 | |
| 20 | 134 |
About Haleh Saber
Haleh Saber is a scholar working on Genetics, Hematology and Oncology, having authored 20 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), CAR-T cell therapy research (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Hematology (276 citations), Genetics (243 citations) and Oncology (606 citations). Haleh Saber has collaborated with scholars based in United States, Egypt and United Kingdom. Frequent co-authors include John K. Leighton, Richard Pazdur, Ann T. Farrell, Robert Justice, Jeffrey C. Hansen, Borries Demeler, Rajeshwari Sridhara, Brian Booth, David E. Morse and Robert C. Kane. Their work appears in journals such as Nature Reviews Drug Discovery, Clinical Cancer Research and Biophysical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.